Conjunctivitis
📧 Sign up to get email alerts when something new happens for Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-15EMA Authorised: Verkazia (ciclosporin) — Santen Oy
EMA has authorised Verkazia (ciclosporin) from Santen Oy for the treatment of conjunctivitis and keratitis. The product has orphan medicinal…
-
FDA approval · 2025-09-30FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for Neomycin and Polymyxin B Sulfates and Hydrocortisone, a combination antibioti…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada
A clinical trial update assessing the burden of recreational water illness from cyanobacteria and their toxins at freshwater beaches in Cana…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC
Clinical trial update on Zamidine eye drops (hexamidine diisethionate) for prophylaxis in ophthalmic surgery, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Zanzibar Arts for Children's Eyesight Pilot Trial [NA]
A pilot eye-health trial called Zanzibar Arts for Children's Eyesight, sponsored by Queen's University Belfast, has completed. It studied my…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: The Effects of a Large Language Model on Clinical Questioning Skills [NA]
This completed clinical trial from Sun Yat-sen University evaluated the impact of a large language model on clinicians' questioning skills a…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants [Phase 2]
Phase 2 trial evaluating subcutaneous anti-Bet v 1 monoclonal antibodies showed efficacy in reducing allergic rhinitis and conjunctivitis sy…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Investigating Epstein-Barr Virus Associated Conjunctivitis
A Moorfields Eye Hospital clinical trial is enrolling participants to study Epstein-Barr virus-associated conjunctivitis.
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and potential efficacy of a cell therapy in patients with cicatricial conjunctivitis and re…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Efficacy of Zinc Fortified Fermented Wheat Flour [NA]
Completed clinical trial evaluating zinc-fortified fermented wheat flour for malnutrition and diabetes-related outcomes, with observations o…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
The clinical trial assessed how often SARS-CoV-2 could be detected in conjunctival swab samples from patients with conjunctivitis during the…
-
FDA approval · 2024-01-09FDA Approved: FLUOROMETHOLONE OPHTHALMIC SUSPENSION — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC’s fluorometholone ophthalmic suspension under an Original Application (ANDA216348).
-
FDA approval · 2023-07-21FDA Approved: NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Neomycin sulfate, polymyxin B sulfate, and dexamethasone ophthalmic suspension from Bausch & Lom…
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: A Study of ADX-102 in Subjects With Allergic Conjunctivitis [Phase 2]
Phase 2 trial of ADX-102 in allergic conjunctivitis completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial assessing Anti-Bet v 1 monoclonal antibodies for reducing symptoms of seasonal allergic rhinitis; study completed with results…
-
FDA approval · 2021-12-10FDA Approved: MAXIDEX — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for MAXIDEX (dexamethasone) by Harrow Eye, LLC.
-
FDA approval · 2021-03-25FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize an extended-release oral suspension formulation of carbinoxamine maleate, submitted by …
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Reducing Adenoviral Patient Infected Days [NA]
Completed clinical trial investigating reducing adenoviral infection days in conjunctivitis patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis [Phase 2]
Phase 2 trial update for mapracorat ophthalmic formulation in subjects with allergic conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% [Phase 4]
Phase 4 trial evaluating the safety and efficacy of Lotemax Ophthalmic Suspension 0.5% has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects [Phase 1]
Phase 1 trial comparing PRO-174 to Sophixín Ofteno® for safety and tolerability on the ocular surface in healthy subjects; completed with re…
-
FDA approval · 2018-06-06FDA Approved: PRED MILD — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for PRED MILD (prednisolone acetate) by Allergan, Inc., adding a supplemental approval for this opht…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Epidemiology of Conjunctivitis in the Emergency Department
This completed clinical trial update reports on the epidemiology of acute conjunctivitis presenting to emergency departments.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Screening for NEI Clinical Studies
NEI-sponsored clinical trial screening has completed screening for multiple ocular studies, covering conjunctivitis, iritis, keratitis, reti…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation and Treatment of Patients With Corneal and External Diseases
This clinical trial update reports on the evaluation and treatment of corneal and external eye diseases. The study included conditions such …